363 related articles for article (PubMed ID: 24156390)
1. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations.
Abdelkader H; Alani AW; Alany RG
Drug Deliv; 2014 Mar; 21(2):87-100. PubMed ID: 24156390
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications.
Chen S; Hanning S; Falconer J; Locke M; Wen J
Eur J Pharm Biopharm; 2019 Nov; 144():18-39. PubMed ID: 31446046
[TBL] [Abstract][Full Text] [Related]
3. Niosomes in sustained and targeted drug delivery: some recent advances.
Azeem A; Anwer MK; Talegaonkar S
J Drug Target; 2009 Nov; 17(9):671-89. PubMed ID: 19845484
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
[TBL] [Abstract][Full Text] [Related]
5. A review on novel vesicular drug delivery: proniosomes.
Yasam VR; Jakki SL; Natarajan J; Kuppusamy G
Drug Deliv; 2014 Jun; 21(4):243-9. PubMed ID: 24128089
[TBL] [Abstract][Full Text] [Related]
6. Niosomes from 80s to present: the state of the art.
Marianecci C; Di Marzio L; Rinaldi F; Celia C; Paolino D; Alhaique F; Esposito S; Carafa M
Adv Colloid Interface Sci; 2014 Mar; 205():187-206. PubMed ID: 24369107
[TBL] [Abstract][Full Text] [Related]
7. Current advances in niosomes applications for drug delivery and cancer treatment.
Moammeri A; Chegeni MM; Sahrayi H; Ghafelehbashi R; Memarzadeh F; Mansouri A; Akbarzadeh I; Abtahi MS; Hejabi F; Ren Q
Mater Today Bio; 2023 Dec; 23():100837. PubMed ID: 37953758
[TBL] [Abstract][Full Text] [Related]
8. Current Advances in Specialised Niosomal Drug Delivery: Manufacture, Characterization and Drug Delivery Applications.
Witika BA; Bassey KE; Demana PH; Siwe-Noundou X; Poka MS
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077066
[TBL] [Abstract][Full Text] [Related]
9. Nano-niosomes as nanoscale drug delivery systems: an illustrated review.
Moghassemi S; Hadjizadeh A
J Control Release; 2014 Jul; 185():22-36. PubMed ID: 24747765
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
Bendas ER; Abdullah H; El-Komy MH; Kassem MA
Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
[TBL] [Abstract][Full Text] [Related]
11. Niosomes from alpha,omega-trioxyethylene-bis(sodium 2-dodecyloxy-propylenesulfonate): preparation and characterization.
Muzzalupo R; Tavano L; Trombino S; Cassano R; Picci N; La Mesa C
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):200-7. PubMed ID: 18378125
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study.
Gupta PN; Mishra V; Rawat A; Dubey P; Mahor S; Jain S; Chatterji DP; Vyas SP
Int J Pharm; 2005 Apr; 293(1-2):73-82. PubMed ID: 15778046
[TBL] [Abstract][Full Text] [Related]
13. Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin.
Tavano L; Alfano P; Muzzalupo R; de Cindio B
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):333-9. PubMed ID: 21684725
[TBL] [Abstract][Full Text] [Related]
14. Controlled self-assembly of monodisperse niosomes by microfluidic hydrodynamic focusing.
Lo CT; Jahn A; Locascio LE; Vreeland WN
Langmuir; 2010 Jun; 26(11):8559-66. PubMed ID: 20146467
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Review on Niosomes as a Tool for Advanced Drug Delivery.
Sharma S; Garg A; Agrawal R; Chopra H; Pathak D
Pharm Nanotechnol; 2024; 12(3):206-228. PubMed ID: 37496251
[TBL] [Abstract][Full Text] [Related]
16. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles.
Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J
J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277
[TBL] [Abstract][Full Text] [Related]
17. Proniosomes as drug carriers.
Sankar V; Ruckmani K; Durga S; Jailani S
Pak J Pharm Sci; 2010 Jan; 23(1):103-7. PubMed ID: 20067875
[TBL] [Abstract][Full Text] [Related]
18. Niosomes from glucuronic acid-based surfactant as new carriers for cancer therapy: preparation, characterization and biological properties.
Tavano L; Aiello R; Ioele G; Picci N; Muzzalupo R
Colloids Surf B Biointerfaces; 2014 Jun; 118():7-13. PubMed ID: 24709252
[TBL] [Abstract][Full Text] [Related]
19. Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants.
Waddad AY; Abbad S; Yu F; Munyendo WL; Wang J; Lv H; Zhou J
Int J Pharm; 2013 Nov; 456(2):446-58. PubMed ID: 23998955
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system.
Hasan AA; Madkor H; Wageh S
Drug Deliv; 2013; 20(3-4):120-6. PubMed ID: 23651102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
